ESMO 2022 Conference Coverage
ESMO 2022 on HER2-Low Inflammatory Breast Cancer: Clinicopathologic Features and Prognostic Implications
By
ESMO 2022 Conference Coverage
FEATURING
Paolo Tarantino
By
ESMO 2022 Conference Coverage
FEATURING
Paolo Tarantino
Login to view comments.
Click here to Login
